Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 64

Sort by

Sort Order Select

Journal Articles

Anticoagulant Therapy in Patients with Severe Factor XI Deficiency

Mar Gutierrez Alvarino, Maria Isabel Rivas Pollmar, Nora Butta, Eduardo Garcia Perez, Victor Jimenez Yuste, Monica Martin Salces, Jose martin De Bustamante, maria Jesus Blanco Bañares, Mikel fernandez Artazkoz, Matias gabriel Facal, Patricia Gonzalez Marugan, Maria Asunción Hernandez Arriaza, María Teresa Álvarez Román

Blood (2024) 144 (Supplement 1): 5563.

https://doi.org/10.1182/blood-2024-204709

Published: 2024

Journal Articles

Monitoring the Hemostatic Effects of Inhibitory Alloantibodies in Von Willebrand Disease Using Global Coagulation Assays

Elena G Arias-Salgado, Nora Butta, Paula Acuña, Elena Monzón Manzano, Monica Martin Salces, Maria Isabel Rivas Pollmar, Rick Kapur, Víctor Jiménez-Yuste, María Teresa Alvarez-Román

Blood (2024) 144 (Supplement 1): 5470.

https://doi.org/10.1182/blood-2024-210405

Published: 2024

Journal Articles

Fourth Interim Analysis of the Hem Powr Study: A Post Hoc Analysis of Real-World Effectiveness and Safety of Damoctocog Alfa Pegol in Adolescent and Older Patients with Hemophilia a

Mark T Reding, María Teresa Alvarez-Román, Giancarlo Castaman, Maissaa Janbain, Tadashi Matsushita, Karina Meijer, Kathrin Schmidt, Johannes Oldenburg

Blood (2024) 144 (Supplement 1): 3968.

https://doi.org/10.1182/blood-2024-205121

Published: 2024

Journal Articles

Concizumab As a Possible Treatment for Bleeding Disordersof Unknown Cause

Paula Acuña, Elena Monzón Manzano, María Teresa Alvarez-Román, Elena G Arias-Salgado, Eduardo Garcia Perez, Monica Martin Salces, Maria Isabel Rivas Pollmar, Rick Kapur, Victor Jimenez Yuste, Nora Butta

Blood (2024) 144 (Supplement 1): 3977.

https://doi.org/10.1182/blood-2024-200067

Published: 2024

Journal Articles

B-Cell Distribution in Immune Thrombocytopenia and Its Relation to Ageing

Elena Monzón Manzano, María Teresa Alvarez-Román, Lucía del Pino, Paula Acuña, Rick Kapur, Leendert Porcelijn, Monica Martin Salces, Elena G Arias-Salgado, Maria Isabel Rivas Pollmar, Ana Mendoza, Eduardo López Granados, Victor Jimenez Yuste, Nora Butta

Blood (2024) 144 (Supplement 1): 2569.

https://doi.org/10.1182/blood-2024-202993

Published: 2024

Journal Articles

Clinical Outcomes over 3 Years of Once-Weekly Efanesoctocog Alfa Treatment in Adults and Adolescents with Severe Hemophilia A: Second Interim Analysis from the Phase 3 XTEND-ed Long-Term Extension Study

Robert Klamroth, Stephanie P'ng, Sophie Susen, Davide Matino, Pratima Chowdary, Angela C Weyand, Toshko Lissitchkov, Young-Shil Park, María Teresa Alvarez-Román, Liqi Feng, Helena Palmborg, Jennifer Dumont, Elena Santagostino, Lara Mamikonian, Keiji Nogami

Blood (2024) 144 (Supplement 1): 717.

https://doi.org/10.1182/blood-2024-204533

Published: 2024

Journal Articles

Use of Avatrombopag in Patients with Immune Thrombocytopenia: Interim Analysis of the Phase 4 Adopt Study

María Eva Mingot-Castellano, María Teresa Alvarez-Román, María Luisa Lozano, Wolfgang Miesbach, Hafiz Qureshi, Vickie McDonald, Milica Putnik, Jessica Zhang, Nina Skuban, Viridiana Cano Garcia, Stefan Lethagen

Blood (2024) 144 (Supplement 1): 714.

https://doi.org/10.1182/blood-2024-203491

Published: 2024

Journal Articles

Avespa Study: Effectiveness and Safety of Avatrombopag in Immune Thrombocytopenia (ITP). a Real-World Study of the Spanish ITP Group (GEPTI)

Blood (2024) 144 (Supplement 1): 713.

https://doi.org/10.1182/blood-2024-200861

Published: 2024

Journal Articles

Avatrombopag in Immune Thrombocytopenia (ITP). Real-Life Experience of Its Use in Hospitals within the Community of Madrid, Spain (AVAMAD STUDY)

María José Llácer Ferrandis, Silvia Monsalvo Saornil, Almudena De Laiglesia, Celia Martínez Vázquez, María Menor Gómez, Esther Chica Gullón, Gloria Pérez Segura, Nuria Revilla, Teresa Arquero, Ariana Ortúzar Pasalodos, Maria Teresa Alvarez Roman, Isabel González-Gascón, Gemma Moreno Jiménez, Cristina Pascual Izquierdo

Blood (2023) 142 (Supplement 1): 3961.

https://doi.org/10.1182/blood-2023-186292

Published: 2023

Journal Articles

Coagulation in Patients with Immune Thrombocytopenia and Other Associated Autoimmune Disorders

Nora Butta, Elena Monzón Manzano, Paula Acuña, Elena G Arias-Salgado, Maria Isabel Rivas Pollmar, Monica Martin Salces, Ana Mendoza-Martínez, Víctor Jiménez-Yuste, Waleed Ghanima, Maria Teresa Álvarez-Roman

Blood (2023) 142 (Supplement 1): 3962.

https://doi.org/10.1182/blood-2023-188452

Published: 2023

Journal Articles

Once-Weekly Efanesoctocog Alfa Prophylaxis Provided High Sustained Factor VIII Activity Levels, Independent of Blood Group, in Children <12 Years of Age with Severe Hemophilia A

Flora Peyvandi, Cristina Tarango, Mindy Simpson, Manuela Albisetti, Maria Teresa Álvarez-Roman, Anthony KC Chan, Julie Curtin, Linda Bystrická, Elena Santagostino, Ekaterina Gresko, Sriya Gunawardena, Chandravathi Vage, Nancy Wong

Blood (2023) 142 (Supplement 1): 506.

https://doi.org/10.1182/blood-2023-188649

Published: 2023

Journal Articles

Monitoring of Hemostatic Status and Treatment Response in Von Willebrand Disease Using a Microchip Flow Chamber Assay

Elena G Arias-Salgado, Paula Acuña, Elena Monzón Manzano, Monica Martin Salces, Maria Isabel Rivas Pollmar, Pilar Lopez Gotor, Nora Butta, Cedric R. Hermans, Víctor Jiménez-Yuste, Maria Teresa Álvarez-Roman

Blood (2023) 142 (Supplement 1): 5396.

https://doi.org/10.1182/blood-2023-187360

Published: 2023

Journal Articles

Impact of Age on Hemostasis of Patients with Immune Thrombocytopenia

Elena Monzón Manzano, Maria Teresa Álvarez-Roman, Paula Acuña, Elena G Arias-Salgado, Raquel Ramírez Martín, Maria Cristina Pascual Izquierdo, Maria Isabel Rivas Pollmar, Monica Martin Salces, Waleed Ghanima, Víctor Jiménez-Yuste, Nora Butta

Blood (2023) 142 (Supplement 1): 1211.

https://doi.org/10.1182/blood-2023-185706

Published: 2023

Journal Articles

Relationship between Molecular Profile and Platelet Function and Thrombin Generation in Patients with Essential Thrombocytemia

Mercedes Gasior Kabat, Elena Monzón Manzano, Paula Acuña, María Teresa Alvarez Román, Elena G Arias-Salgado, María Isabel Rivas Pollmar, Matias Facal Giuliani, Patricia Gonzalez Marugan, Sara García Barcenilla, Fernando Gomez Aguado, Concepción Ramos Castro, Cédric Hermans, Víctor Jiménez Yuste, Nora V. Butta

Blood (2022) 140 (Supplement 1): 12266–12267.

https://doi.org/10.1182/blood-2022-167776

Published: 2022

Journal Articles

Interim Subgroup Analysis of the Effectiveness and Safety of Damoctocog Alfa Pegol Prophylaxis in Previously Treated Patients with Hemophilia A Treated Every 5 or Every 7 Days: Results from the Real-World Observational HEM-POWR Study

Mark T Reding, María Teresa Alvarez Román, Martin Sanabria, Giancarlo Castaman, Maissaa Janbain, Tadashi Matsushita, Karina Meijer, Kathrin Schmidt, Johannes Oldenburg

Blood (2022) 140 (Supplement 1): 5612–5614.

https://doi.org/10.1182/blood-2022-169159

Published: 2022

Journal Articles

Predictive Value of Platelet Sequestration Studies in Splenectomy Response

Ana Mendoza, Nora V. Butta, Elena Monzón Manzano, Paula Acuña, Elena G Arias-Salgado, María Isabel Rivas Pollmar, Mónica Martín Salces, Mar Gutierrez, Eduardo Garcia Perez, Andres Ramirez Lopez, Leticia Gómez Serrano, Jose Manuel Martin de Bustamante Gonzalez-Iglesias, Barbara Martínez de Miguel, Elena Martínez Montalbán, Elena Dobra, Cédric Hermans, Víctor Jiménez-Yuste, María Teresa Alvarez Román

Blood (2022) 140 (Supplement 1): 2649–2651.

https://doi.org/10.1182/blood-2022-156930

Published: 2022

Journal Articles

Discontinuation of Thrombopoietin Receptor Agonists: A 10 Year Real-World Experience from an Academic Hospital in Madrid

Andres Ramirez Lopez, María Teresa Alvarez Román, María Isabel Rivas Pollmar, Mónica Martín Salces, Mar Gutierrez, Eduardo Garcia Perez, Elena G Arias-Salgado, Elena Monzón Manzano, Paula Acuña, Víctor Jiménez Yuste, Nora V. Butta, Cédric Hermans

Blood (2022) 140 (Supplement 1): 2676–2677.

https://doi.org/10.1182/blood-2022-158266

Published: 2022

Journal Articles

Eptacog Beta Efficacy in Treating Mild or Moderate Bleeds in Target Joints of Individuals with Hemophilia A or B and Inhibitors in PERSEPT 1

Blood (2022) 140 (Supplement 1): 5597–5599.

https://doi.org/10.1182/blood-2022-156110

Published: 2022

Journal Articles

Follow-up and Evaluation of the Efficacy of the Hemostatic Treatment in Congenital FVII Deficiency during Development of Inhibitor

María Isabel Rivas Pollmar, Elena G Arias-Salgado, María Teresa Alvarez Román, Elena Monzón Manzano, Paula Acuña, Mónica Martín Salces, Sara García Barcenilla, Nora V. Butta, Cédric Hermans, Víctor Jiménez-Yuste

Blood (2022) 140 (Supplement 1): 8462–8463.

https://doi.org/10.1182/blood-2022-170037

Published: 2022

Journal Articles

Anxiety and Depression in Patients with Haemophilia a without Inhibitors and Their Caregivers Included in Hemolife, Non Interventional Study in the Spanish Population

María Teresa Alvarez Román, Maria Garcia Dasi, Laura Entrena Ureña, Olga Benitez Hidalgo, Ramiro Jose Nunez Vazquez, Hortensia de la Corte, Alaitz Etxaide Aranbarri, Itziar Guerra, Maria Eva Mingot, Inmaculada Soto

Blood (2022) 140 (Supplement 1): 11326–11327.

https://doi.org/10.1182/blood-2022-157321

Published: 2022

NARROW

Anticoagulant Therapy in Patients with Severe Factor XI Deficiency

Monitoring the Hemostatic Effects of Inhibitory Alloantibodies in Von Willebrand Disease Using Global Coagulation Assays

Fourth Interim Analysis of the Hem Powr Study: A Post Hoc Analysis of Real-World Effectiveness and Safety of Damoctocog Alfa Pegol in Adolescent and Older Patients with Hemophilia a

Concizumab As a Possible Treatment for Bleeding Disordersof Unknown Cause

B-Cell Distribution in Immune Thrombocytopenia and Its Relation to Ageing

Clinical Outcomes over 3 Years of Once-Weekly Efanesoctocog Alfa Treatment in Adults and Adolescents with Severe Hemophilia A: Second Interim Analysis from the Phase 3 XTEND-ed Long-Term Extension Study

Use of Avatrombopag in Patients with Immune Thrombocytopenia: Interim Analysis of the Phase 4 Adopt Study

Avespa Study: Effectiveness and Safety of Avatrombopag in Immune Thrombocytopenia (ITP). a Real-World Study of the Spanish ITP Group (GEPTI)

Avatrombopag in Immune Thrombocytopenia (ITP). Real-Life Experience of Its Use in Hospitals within the Community of Madrid, Spain (AVAMAD STUDY)

Coagulation in Patients with Immune Thrombocytopenia and Other Associated Autoimmune Disorders

Once-Weekly Efanesoctocog Alfa Prophylaxis Provided High Sustained Factor VIII Activity Levels, Independent of Blood Group, in Children <12 Years of Age with Severe Hemophilia A

Monitoring of Hemostatic Status and Treatment Response in Von Willebrand Disease Using a Microchip Flow Chamber Assay

Impact of Age on Hemostasis of Patients with Immune Thrombocytopenia

Relationship between Molecular Profile and Platelet Function and Thrombin Generation in Patients with Essential Thrombocytemia

Interim Subgroup Analysis of the Effectiveness and Safety of Damoctocog Alfa Pegol Prophylaxis in Previously Treated Patients with Hemophilia A Treated Every 5 or Every 7 Days: Results from the Real-World Observational HEM-POWR Study

Predictive Value of Platelet Sequestration Studies in Splenectomy Response

Discontinuation of Thrombopoietin Receptor Agonists: A 10 Year Real-World Experience from an Academic Hospital in Madrid

Eptacog Beta Efficacy in Treating Mild or Moderate Bleeds in Target Joints of Individuals with Hemophilia A or B and Inhibitors in PERSEPT 1

Follow-up and Evaluation of the Efficacy of the Hemostatic Treatment in Congenital FVII Deficiency during Development of Inhibitor

Anxiety and Depression in Patients with Haemophilia a without Inhibitors and Their Caregivers Included in Hemolife, Non Interventional Study in the Spanish Population

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only